Analysis of phenylalanine hydroxylase genotypes and hyperphenylalaninemia phenotypes using L-[1-13C]phenylalanine oxidation rates in vivo: A pilot study

Pediatric Research

Volumn 42, Issue 4, 1997, Pages 430-435

  Treacy, Eileen P ^a,d   Delente, Jacques J ^b   Elkas, Gay ^a   Carter, Kevin ^a   Lambert, Marie ^c   Waters, Paula J ^a   Scriver, Charles R ^a  

^a MCGILL UNIVERSITY   (Canada)

^b A and R Materials Inc   (United States)

^c UNIVERSITY OF MONTREAL   (Canada)

^d MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE;

ADOLESCENT; ADULT; AMINO ACID ANALYSIS; ARTICLE; CHILD; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOSITY; HUMAN; HYPERPHENYLALANINEMIA; MALE; PHENOTYPE; PHENYLKETONURIA; PRIORITY JOURNAL;

EID: 0030849458     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199710000-00002     Document Type: Article

References (31)

1. Scriver CR, Kaufman S, Eisensmith R, Woo SL 1995 The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle V (eds) The Metabolic and Molecular Bases of Inherited Disease, 7th Ed. McGraw-Hill, New York, pp 1015-1075
2. Nowacki P, Byck S, Prevost L, Scriver CR (curators) 1997 PAH mutation analysis consortium Database: a database for disease-producing and other allelic variation at the human PAH locus. Nucleic Acids Res 25:139-142
3. Ramus SJ, Forrest S, Pitt DB, Saleeba JA, Cotton RGH 1993 Comparison of genotype and intellectual phenotype in untreated PKU patients. J Med Genet 30:401-405
4. Scriver CR, Gregory DM, Sovetts D, Tissenbaum G 1985 Normal plasma free amino acid values in adults: the influence of some common physiological variables. Metabolism 34:868-873
5. Guttler F, Lou H 1990 Phenylketonuria and Hyperphenylalaninaemia. In: Fernandes J. Saudubray J-M, Tada K (eds) Inborn Metabolic Diseases: Diagnosis and Treatment. Springer-Verlag, Berlin, pp 161-174
6. Smith I, Brenton D 1995 Hyperphenylalaninaemia. In: Saudubray J-M. Fernandes J (eds) Inborn Metabolic Diseases: Diagnosis and Treatment, 2nd Ed. Springer-Verlag, Berlin, pp 140-160
7. Medical Research Council, UK Working Party on Phenylketonuria 1993 Recommendations on the dietary management of phenylketonuria. Arch Dis Child 68:426-427
8. Guldherg P, Guttler F 1994 Mutations in the phenylalanine hydroxylase gene: methods for their characterization. Acta Paediatr Suppl. 83(suppl407):27-33
9. 14C]pyryvate in normal, acrotnegalic and HGH-treated human subjects. Acta Endocrinol 65:155-169
10. Haycock GB, Schwartz GJ, Wisotsky DH 1978 Geometric method of measuring body surface areas. A height-weight formula validated in infants, children and adults. J Pediatr 93:62-66
11. Rosenblatt D, Scriver CR 1968 Heterogeneity in genetic control of phenylalanine metabolism in man. Nature 218:677-678
12. Gold RJM, Maag UR, Neal JL, Scriver CR 1974 The use of biochemical data in screening for mutant alleles and in genetic counselling. Ann Hum Genet 37:315-326
13. Okano Y, Eisensmith RC, Guttler F, Lichter-Konecki U, Konecki D, Trefz FK, Dasovich M, Wang T, Henriksen K, Lou H, Woo SLC 1991 Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med 324:1232-1236
14. 13C]phenylalanine oxidation. Am J Hum Genet 59(suppl):A293(abstr 1700)
15. Eisensmith RC, Martinez DR, Kuzmin AI, Gollsov AA, Brown A, Singh R, Elsas II, LJ, Woo SLC 1996 Molecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous southeastern US population. Pediatrics 97:512-516
16. Svensson E, Dobeln U, Eisensmith RC, Hagenfeldt L, Woo LSC 1992 Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients. Eur J Pediatr 152:132-139
17. Sanchez M, EL-Khoury AE, Castillo L, Chapman TE, Young VR 1995 Phenylalanine and tyrosine kinetics in young men throughout a continuous 24-h period, at a low phenylalanine intake. Am J Clin Nutr 61:555-570
18. 13C]tyrosine in the postabsorptive state. Metabolism 31:999-1005
19. Thompson GN, Halliday P 1990 Significant phenylalanine hydroxylation in vivo in patients with classical phenylketonuria. J Clin Invest 80:317-322
20. Trefz FK, Erlenmaier T, Hunneman DH, Bartholomé K, Lutz P 1979 Sensitive in vivo assay of the phenylalanine hydroxylating system with a small intravenous dose of heptadeutero-L-phenylalanine using high pressure liquid chromatography and capillary gas chromatography/mass fragmentography. Clin Chim Acta 99:211-230
21. Treacy EP, Pitt JJ, Sellar K, Thompson GN, Ramus S, Cotton RGH 1996 In vivo disposal of phenylalanine in phenylketonuria: a study of two siblings. J Inherit Metab Dis 19:595-602
22. 13C]phenylalanine. Am J Physiol 259:E835-E843
23. Salter M, Knowles RG, Pogson CI 1986 Quantification of the importance of individual steps in the control of aromatic amino acid metabolism. Biochem J 234:635-647
24. Berke EM, Gardner AW, Goran MI, Poehlman ET 1992 Resting metabolic rate and the influence of the pretesting environment. Am J Clin Nutr 55:626-629
25. 2]tyrosine oral-tracer studies at an intermediate phenylalanine intake to estimate requirements in adults. Am J Clin Nutr 65:473-488
26. Bartholomé K, Lutz P, Bickel H 1975 Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylalaninaemia. Pediatr Res 9:899-903
27. Kaufman S, Max E, Kang ES 1975 Phenylalanine hydroxylase activity in liver biopsies from hyperphenylalaninemia heterozygotes: deviation from proportionality with gene dosage. Pediatr Res 9:6.32-634
28. Kacser H, Burns JA 1981 The molecular basis of dominance. Genetics 97:639-666
29. Kayaalp E, Treacy E, Waters PJ, Byck S, Nowacki P, Scriver CR 1997 Human PAH mutation and hyperphenylalaninemia phenotypes: a meta-analysis of genotype-phenotype correlations. Am J Hum Genet (in press)
30. Tessari P, Inchiostro S, Barazzoni R, Zanetti M, Vettore M, Biolo G, Iori E, Kiwanuka E, Tiengo A 1996 Hyperglucagonemia stimulates phenylalanine oxidation in humans. Diabetes 45:463-470
31. 13C-phenylalanine oxidation in hyperphenylalaninemia. Pediatr Res 39:4(abstr 876)